0001593968-22-001741.txt : 20221219 0001593968-22-001741.hdr.sgml : 20221219 20221219162416 ACCESSION NUMBER: 0001593968-22-001741 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221216 FILED AS OF DATE: 20221219 DATE AS OF CHANGE: 20221219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ignelzi Troy A. CENTRAL INDEX KEY: 0001579829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 221471398 MAIL ADDRESS: STREET 1: C/O ESPERION THERAPEUTICS, INC. STREET 2: 46701 COMMERCE CENTER DRIVE CITY: PLYMOUTH STATE: MI ZIP: 48170 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2022-12-16 0001771917 Karuna Therapeutics, Inc. KRTX 0001579829 Ignelzi Troy A. C/O KARUNA THERAPEUTICS, INC. 99 HIGH STREET, 26TH FLOOR BOSTON MA 02110 false true false false Chief Financial Officer Common Stock 2022-12-16 4 M false 10869 9.2 A 20839 D Common Stock 2022-12-16 4 M false 371 9.2 A 21210 D Common Stock 2022-12-16 4 M false 627 9.2 A 21837 D Option (right to buy) 9.20 2022-12-16 4 M false 10869 0 D 2029-03-21 Common Stock 10869 110743 D Option (right to buy) 9.20 2022-12-16 4 M false 371 0 D 2029-03-28 Common Stock 371 8559 D Option (right to buy) 9.20 2022-12-16 4 M false 627 0 D 2029-04-07 Common Stock 627 626 D This option vested and became exercisable as to 1/4th of the shares underlying the option award on March 1, 2020, and continues to vest as to an additional 1/8th of the shares on each six month anniversary thereafter. This option vested as to 1/36th of the shares underlying the option award on each one month anniversary of the vesting commencement date of March 1, 2019. /s/ Troy Ignelzi 2022-12-19